W. Lau

Micafungin (FK463), alone or in combination with other systemic antifungal agents, for the treatment of acute invasive aspergillosis

David W. Denning, Kieren A. Marr, W. Lau et al. · Journal of Infection · 2006 · 294 citations · Full text

Safety, Tolerability, and Pharmacokinetics of Micafungin (FK463) in Febrile Neutropenic Pediatric Patients

Nita L. Seibel, Cindy L. Schwartz, Antonio Arrieta et al. · Antimicrobial Agents and Chemotherapy · 2005 · 246 citations · Full text

International, open-label, noncomparative, clinical trial of micafungin alone and in combination for treatment of newly diagnosed and refractory candidemia

Luis Ostrosky‐Zeichner, D. P. Kontoyiannis, John Raffalli et al. · European Journal of Clinical Microbiology & Infectious Diseases · 2005 · 189 citations

Antifungal Agent, Antifungal Agents, Medicine +5

Pharmacokinetic and Maximum Tolerated Dose Study of Micafungin in Combination with Fluconazole versus Fluconazole Alone for Prophylaxis of Fungal Infections in Adult Patients Undergoing a Bone Marrow or Peripheral Stem Cell Transplant

J. Hiemenz, Pablo J. Cagnoni, David Simpson et al. · Antimicrobial Agents and Chemotherapy · 2005 · 150 citations · Full text

A randomized, double blind, comparative trial of micafungin (FK463) vs. fluconazole for the treatment of oesophageal candidiasis

N. T. E. De Wet, A J Bester, J. Viljoen et al. · Alimentary Pharmacology & Therapeutics · 2005 · 146 citations · Full text